journal article·2014-11

Mesenchymal stroma cells trigger early attraction of M1 macrophages and endothelial cells into fibrin hydrogels, stimulating long bone healing without long-term engraftment

Elisabeth Seebach, Holger Freischmidt, Jeannine Holschbach, Jörg Fellenberg, Wiltrud Richter

Acta Biomaterialia· Volume 10· Issue 11
Publisher page

Abstract

Implantation of mesenchymal stroma cells (MSCs) is an attractive approach to stimulate closure of large bone defects but an optimal carrier has yet to be defined. MSCs may display trophic and/or immunomodulatory features or stimulate bone healing by their osteogenic activity. The aim of this study was to unravel whether fibrin hydrogel supports early actions of implanted MSCs, such as host cell recruitment, immunomodulation and tissue regeneration, in long bone defects. Female rats received cell-free fibrin or male MSCs embedded in a fibrin carrier into plate-stabilized femoral bone defects. Removed callus was analyzed for host cell invasion (day 6), local cytokine expression (days 3 and 6) and persistence of male MSCs (days 3, 6, 14 and 28). Fibrin-MSC composites triggered fast attraction of host cells into the hydrogel while cell-free fibrin implants were not invaded. A migration front dominated by M1 macrophages and endothelial progenitor cells formed while M2 macrophages remained sparse. Only MSC-seeded fibrin hydrogel stimulated early tissue maturation and primitive vessel formation at day 6 in line with significantly higher VEGF mRNA levels recorded at day 3. Local TNF-α, IL-1β and IL-10 expression indicated a balanced immune cell activity independent of MSC implantation. Implanted MSCs persisted until day 14 but not day 28. Our results demonstrate that fibrin hydrogel is an attractive carrier for MSC implantation into long bone defects, supporting host cell attraction and pro-angiogenic activity. By this angiogenesis, implant integration and tissue maturation was stimulated in long bone healing independent of long-term engraftment of implanted MSCs.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Mesenchymal stem cell research · Periodontal Regeneration and Treatments · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (59)

Show source-provided references
1. Cellular strategies for enhancement of fracture repair10.2106/JBJS.G.01572 ↗
2. Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine10.3109/14653249.2011.638914 ↗
3. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation10.1016/S0142-9612(02)00618-X ↗
4. Chondrogenesis of mesenchymal stem cells in gel-like biomaterials in vitro and in vivo10.2741/3020 ↗
5. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications10.1177/088532829300700402 ↗
6. Mesenchymal stem cell differentiation in an experimental cartilage defect: restriction of hypertrophy to bone-close neocartilage10.1089/scd.2008.0213 ↗
7. Enhanced early tissue regeneration after matrix-assisted autologous mesenchymal stem cell transplantation in full thickness chondral defects in a minipig model10.3727/096368909X471297 ↗
8. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues10.1097/00007890-196803000-00009 ↗
9. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment10.1016/j.cell.2007.08.025 ↗
10. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement10.1080/14653240600855905 ↗
11. Multilineage potential of adult human mesenchymal stem cells10.1126/science.284.5411.143 ↗
12. Mechanisms involved in the therapeutic properties of mesenchymal stem cells10.1016/j.cytogfr.2009.10.002 ↗
13. The MSC: an injury drugstore10.1016/j.stem.2011.06.008 ↗
14. Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect10.1089/ten.1997.3.173 ↗
15. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects10.2106/00004623-199807000-00007 ↗
16. Repair of large bone defects with the use of autologous bone marrow stromal cells10.1056/NEJM200102013440516 ↗
17. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study10.1089/ten.2006.0271 ↗
18. Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells10.22203/eCM.v021a37 ↗
19. Chondrogenic pre-induction of human mesenchymal stem cells on beta-TCP: enhanced bone quality by endochondral heterotopic bone formation10.1016/j.actbio.2010.01.037 ↗
20. Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration10.1089/ten.tea.2009.0041 ↗
21. Fate of bone marrow stromal cells in a syngenic model of bone formation10.1089/ten.tea.2010.0461 ↗
22. Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo10.1089/ten.tea.2009.0577 ↗
23. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms10.1038/mt.2009.62 ↗
24. The assessment of skeletal maturity in the growing rat
25. Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae10.1007/s002239900723 ↗
26. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization10.1046/j.1365-2141.2003.04669.x ↗
27. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells10.1002/art.10767 ↗
28. The chemokine system in diverse forms of macrophage activation and polarization10.1016/j.it.2004.09.015 ↗
29. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component10.1016/j.biomaterials.2008.11.040 ↗
30. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors10.1634/stemcells.2007-0280 ↗
31. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms10.1161/01.RES.0000118601.37875.AC ↗
32. Biophysical and chemical effects of fibrin on mesenchymal stromal cell gene expression10.1016/j.actbio.2010.05.020 ↗
33. Cellular and molecular mechanisms of bone remodeling10.1074/jbc.R109.041087 ↗
34. Understanding the role of immune regulation in wound healing10.1016/S0002-9610(03)00296-4 ↗
35. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute10.1016/j.bone.2007.06.018 ↗
36. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect10.1038/mt.2009.315 ↗
37. Long-term tracking of segmental bone healing mediated by genetically engineered adipose-derived stem cells: focuses on bone remodeling and potential side effects10.1089/ten.tea.2013.0314 ↗
38. Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation10.1021/pr901110q ↗
39. The secretory profiles of cultured human articular chondrocytes and mesenchymal stem cells: implications for autologous cell transplantation strategies10.3727/096368910X550215 ↗
40. Recruitment of a host’s osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic10.1089/ten.tea.2008.0269 ↗
41. The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model10.1016/j.biomaterials.2009.11.064 ↗
42. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model10.1016/j.biomaterials.2009.09.038 ↗
43. Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells10.1016/j.biomaterials.2011.07.041 ↗
44. Protective and pathogenic functions of macrophage subsets10.1038/nri3073 ↗
45. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages10.1016/j.jim.2011.10.013 ↗
46. Macrophage phenotypes during tissue repair10.1189/jlb.1012512 ↗
47. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis10.1084/jem.20070075 ↗
48. Modulation of the inflammatory response for enhanced bone tissue regeneration10.1089/ten.teb.2008.0038 ↗
49. The early fracture hematoma and its potential role in fracture healing10.1089/ten.teb.2009.0687 ↗
50. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications10.1186/scrt2 ↗
51. MHC expression in syngeneic and allogeneic retinal cell transplants in the rat10.1007/s004170050199 ↗
52. Osteogenesis in a rat model: use of bone marrow cells and biodegradable gelatin matrix carrier
53. Periodontal regeneration using engineered bone marrow mesenchymal stromal cells10.1016/j.biomaterials.2010.06.026 ↗
54. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts10.1097/00007890-199704270-00003 ↗
55. Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro10.1016/j.biomaterials.2009.06.023 ↗
56. The inflammatory potential of biphasic calcium phosphate granules in osteoblast/macrophage co-culture10.1016/j.biomaterials.2005.01.065 ↗
57. Cell sheet transplantation of cultured mesenchymal stem cells enhances bone formation in a rat nonunion model10.1016/j.bone.2009.08.048 ↗
58. Use of a rat cDNA probe specific for the Y chromosome to detect male-derived cells10.1002/j.1939-4640.1997.tb01921.x ↗
59. Immune responses during healing of massive segmental femoral bone defects mediated by hybrid baculovirus-engineered ASCs10.1016/j.biomaterials.2012.06.083 ↗